Skip to main content
. 2013 May 15;5:67–69. doi: 10.1016/j.gynor.2013.05.004

Table 1.

Reported cases of rectovaginal extragastrointestinal stromal tumor.

First author, reference No. of pts. Age, years Tumor size, cm Treatment No. of mitosis per 50 HPF Necrosis Cd117 Cd34 SMA Ki-67 Outcome
Nasu et al. (2004) 1 54 8.5 Surgery 5–10 + + + + N/A Alive at 13 months
Ceballos et al. (2004) 1 75 4.5 Local excision 12–15 + + + N/A Recurrence at 7.5 years
Weppler and Gaertner (2005) 1 66 8 Imatinib > 5 + + N/A N/A
Takano et al. (2006) 1 38 7 Surgery 1–2 N/A + + + N/A Alive at 12 months
Lam et al. (2006) 3 36 4 N/A 15 + + N/A Recurrence at 2 years
48 6 N/A 12 + + + N/A Recurrence at 10 years
61 8 N/A 16 + + N/A N/A
Nagase et al. (2007) 2 42 3.5 Local excision < 1 + + + 20–30 Alive at 4 years
66 5 Surgery + imatinib 2–3 + + 30 Alive at 6 months
Zhang et al. (2009) 1 42 8 Local excision 10 + + + 3 Alive, no time report
Muñoz (present case) 1 15 2 Surgery + TKIs* 40 + + N/A Recurrence at 4 months, 12 months, and 18 months; DOD

HPF, high-power field; N/A, not available; SMA, smooth muscle actin; TKIs, tyrosine kinase inhibitors.